Achieve Life Sciences, Inc. (ACHV)

NASDAQ: ACHV · Real-Time Price · USD

6.42

+0.12 (1.90%)

At close: Jul 31, 2026, 4:00 PM EDT

6.37

-0.05 (-0.80%)

After-hours: Jul 31, 2026, 7:34 PM EDT

Achieve Life Sciences Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	28.08	20.93	12.75	15.55	24.77	43.02
Short-Term Investments	1.19	15.48	21.61	-	-	-
Cash & Short-Term Investments	29.27	36.4	34.36	15.55	24.77	43.02
Cash Growth	25.91%	5.95%	121.02%	-37.24%	-42.42%	20.00%
Other Receivables	-	-	-	0.11	0.11	0.15
Total Trade Receivables	-	-	-	0.11	0.11	0.15
Other Current Assets	1.79	3.49	2.11	1.33	2.45	1.42
Total Current Assets	31.06	39.89	36.47	16.98	27.33	44.59
Net Property, Plant & Equipment	0.05	0.06	0.12	0.07	0.12	0.06
Other Intangible Assets	0.7	0.75	0.97	1.2	1.42	1.64
Goodwill	1.03	1.03	1.03	1.03	1.03	1.03
Other Long-Term Assets	0.27	0.05	0.04	0.09	0.07	0.18
Total Assets	33.11	41.79	38.63	19.37	29.97	47.52

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Accounts Payable	0.83	0.87	1.95	0.62	1.66	0.84
Accrued Expenses	5.37	2.89	4.68	2.94	3.81	3.64
Current Portion of Long-Term Debt	5.63	3.77	0.06	16.73	16.13	0.07
Other Current Liabilities	-	1.56	-	0.53	-	-
Total Current Liabilities	11.83	9.08	6.68	20.81	21.6	4.55
Long-Term Debt	9.32	11.19	9.84	0.01	0.07	14.92
Other Long-Term Liabilities	1.27	-	1.15	-	-	-
Total Long-Term Liabilities	10.59	11.19	10.99	0.01	0.07	14.92
Total Liabilities	22.43	20.27	17.73	20.82	21.67	19.47

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Common Stock	0.12	0.12	0.1	0.09	0.09	0.08
Additional Paid-in Capital	280.95	281.61	226.34	164.21	144.15	121.55
Accumulated Other Comprehensive Income	0	0.01	0.03	0	0	0
Retained Earnings	-270.39	-260.23	-205.58	-165.75	-135.94	-93.59
Shareholders' Equity	10.68	21.52	20.9	-1.45	8.3	28.04
Total Liabilities & Equity	33.11	41.79	38.63	19.37	29.97	47.52

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Total Debt	14.95	14.95	9.89	16.73	16.2	14.99
Net Cash (Debt)	14.32	21.45	24.47	-1.19	8.57	28.03
Net Cash Growth	7.77%	-12.32%	-	-	-69.41%	-21.45%
Net Cash Per Share	0.30	0.49	0.76	-0.06	0.81	3.45
Book Value	10.68	21.52	20.9	-1.45	8.3	28.04
Book Value Per Share	0.22	0.49	0.65	-0.07	0.78	3.45
Tangible Book Value	8.95	19.73	18.89	-3.68	5.85	25.37
Tangible Book Value Per Share	0.19	0.45	0.59	-0.19	0.55	3.12

SEC Filings: 10-K · 10-Q